We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Pentixapharm Holding AG | TG:PTP | Tradegate | Ordinary Share |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.04 | -1.34% | 2.94 | 2.94 | 3.025 | 3.015 | 2.935 | 2.96 | 7,271 | 17:58:19 |
Hot Features
Premium
RNS Number:9375I
Profile Therapeutics PLC
19 March 2003
DEALINGS BY DIRECTORS
1) NAME OF COMPANY
PROFILE THERAPEUTICS PLC
2) NAME OF DIRECTOR
SIMON CONSTANTINE
3) Please state whether notification indicates that it is in respect of
holding of the shareholder named in 2 above or in respect of a
non-beneficial interest or in the case of an individual holder
if it is a holding of that person's spouse or children under the
age of 18 or in respect of an non-beneficial interest
IN RESPECT OF SIMON CONSTANTINE
4) Name of the registered holder(s) and, if more than one holder, the
number of shares held by each of them. (If notified)
SIMON JOHN CONSTANTINE
5) Please state whether notification relates to a person(s) connected
with the Director named in 2 above and identify the connected person(s)
N/A
6) Please state the nature of the transaction. For PEP transactions
please indicate whether general/single co PEP and if discretionary/non
discretionary
PURCHASE
7) Number of shares of
acquired
100,000
8) (0.20%)
of issued Class
N/A
9) Number of shares/amount
of stock disposed
N/A
10) ( N/A %)
of issued Class
11) Class of security
ORDINARY SHARES OF 2P
12) Price per share
29P
13) Date of transaction
18 MARCH 2003
14) Date company informed
18 MARCH 2003
15) Total holding following this notification
100,000
16) Total percentage holding of issued class following this notification
0.20%
IF A DIRECTOR HAS BEEN GRANTED OPTIONS BY THE COMPANY PLEASE
COMPLETE THE FOLLOWING BOXES
17) Date of grant
18) Period during which or date on which exercisable
19) Total amount paid (if any) for grant of the option
20) Description of shares or debentures involved: class, number.
21) Exercise price (if fixed at time of grant) or indication that price
is to be fixed at time of exercise
22) Total number of shares or debentures over which options held
following this notification
23) Any additional information
24) Name of contact and telephone number for queries
JOHN WARD 0870 770 2000
25) Name and signature of authorised company official responsible for
making this notification
Date of Notification 19 MARCH 2003
DEALINGS BY DIRECTORS
1) NAME OF COMPANY
PROFILE THERAPEUTICS PLC
2) NAME OF DIRECTOR
JSH DENYER
3) Please state whether notification indicates that it is in respect of
holding of the shareholder named in 2 above or in respect of a
non-beneficial interest or in the case of an individual holder
if it is a holding of that person's spouse or children under the
age of 18 or in respect of an non-beneficial interest
JSH DENYER, MRS EJ DENYER (WIFE)
JSH DENYER /EJ DENYER (NON-BENEFICIAL)
4) Name of the registered holder(s) and, if more than one holder, the
number of shares held by each of them. (If notified)
SEE 3 ABOVE
5) Please state whether notification relates to a person(s) connected
with the Director named in 2 above and identify the connected person(s)
SEE 3 ABOVE
6) Please state the nature of the transaction. For PEP transactions
please indicate whether general/single co PEP and if discretionary/non
discretionary
SALE
7) Number of shares/amount of
stock acquired
N/A
8) (N/A %)
of issued Class
9) Number of shares
disposed
50,000
10) (1.02%)
of issued Class
11) Class of security
ORDINARY SHARES OF 2P
12) Price per share
29P
13) Date of transaction
18 MARCH 2003
14) Date company informed
18 MARCH 2003
15) Total holding following this notification
JSH DENYER 963,275
JSH DENYER / EJ DENYER (NON-BEN) 486,275
16) Total percentage holding of issued class following this notification
JSH DENYER 1.96%
JSH DENYER / EJ DENYER (NON-BEN) 0.99%
IF A DIRECTOR HAS BEEN GRANTED OPTIONS BY THE COMPANY PLEASE
COMPLETE THE FOLLOWING BOXES
17) Date of grant
18) Period during which or date on which exercisable
19) Total amount paid (if any) for grant of the option
20) Description of shares or debentures involved: class, number.
21) Exercise price (if fixed at time of grant) or indication that price
is to be fixed at time of exercise
22) Total number of shares or debentures over which options held
following this notification
23) Any additional information
SEE DISCLOSURE BELOW
24) Name of contact and telephone number for queries
JOHN WARD 0870 770 2000
25) Name and signature of authorised company official responsible for
making this notification
Date of Notification 19 MARCH 2003
BOX 23. ANY ADDITIONAL INFORMATION
On 17 March 2003, JSH Denyer transferred 26,551 ordinary shares to his wife, Mrs
EJ Denyer, at Nil consideration. Later on 18 March 2003, JSH Denyer sold 10,174
shares and Mrs EJ Denyer sold 26,551 shares. In addition 13,275 shares held on
trust (non-beneficially) by JSH Denyer/EJ Denyer were sold. All three sales
were at a price of 29p per share.
DEALINGS BY DIRECTORS
1) NAME OF COMPANY
PROFILE THERAPEUTICS PLC
2) NAME OF DIRECTOR
SJB SHAW
3) Please state whether notification indicates that it is in respect of
holding of the shareholder named in 2 above or in respect of a
non-beneficial interest or in the case of an individual holder
if it is a holding of that person's spouse or children under the
age of 18 or in respect of an non-beneficial interest
SJB SHAW, MRS MJ SHAW (WIFE)
SJB SHAW / MJ SHAW (NON-BENEFICIAL)
4) Name of the registered holder(s) and, if more than one holder, the
number of shares held by each of them. (If notified)
SEE 3 ABOVE
5) Please state whether notification relates to a person(s) connected
with the Director named in 2 above and identify the connected person(s)
SEE 3 ABOVE
6) Please state the nature of the transaction. For PEP transactions
please indicate whether general/single co PEP and if discretionary/non
discretionary
SALE
7) Number of shares/amount of
stock acquired
N/A
8) (N/A %)
of issued Class
9) Number of shares/amount
of stock disposed
50,000
10) (1-02%)
of issued Class
11) Class of security
ORDINARY SHARES OF 2P
12) Price per share
29P
13) Date of transaction
18 MARCH 2003
14) Date company informed
18 MARCH 2003
15) Total holding following this notification
SJB SHAW 963,275
SJB SHAW / MJ SHAW (NON-BEN) 486,725
16) Total percentage holding of issued class following this notification
SJB SHAW 1.96%
SJB SHAW / MJ SHAW (NON-BEN) 0.99%
IF A DIRECTOR HAS BEEN GRANTED OPTIONS BY THE COMPANY PLEASE
COMPLETE THE FOLLOWING BOXES
17) Date of grant
18) Period during which or date on which exercisable
19) Total amount paid (if any) for grant of the option
20) Description of shares or debentures involved: class, number.
21) Exercise price (if fixed at time of grant) or indication that price
is to be fixed at time of exercise
22) Total number of shares or debentures over which options held
following this notification
23) Any additional information
SEE DISCLOSURE BELOW
24) Name of contact and telephone number for queries
JOHN WARD 0870 770 2000
25) Name and signature of authorised company official responsible for
making this notification
Date of Notification 19 MARCH 2003
BOX 23, ANY ADDITIONAL INFORMATION
On 18 March 2003, SJB Shaw transferred 26,551 ordinary shares to his wife,
Mrs MJ Shaw, at nil consideration. Later on 18 March 2003, SJB Shaw sold
10,174 shares and Mrs MJ Shaw sold 26,551 shares. In addition 13,275 shares
held on trust (non-beneficially) by SJB Shaw/MJ Shaw were sold. All three sales
were at a price of 29p per share.
This information is provided by RNS
The company news service from the London Stock Exchange
END
RDSUKVUROAROAAR
1 Year Pentixapharm Chart |
1 Month Pentixapharm Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
